Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study.

Departments of Nutrition and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
American journal of epidemiology (Impact Factor: 4.98). 02/2009; 169(7):815-28. DOI: 10.1093/aje/kwn409
Source: PubMed

ABSTRACT High-dose beta-carotene supplementation in high-risk persons has been linked to increased lung cancer risk in clinical trials; whether effects are similar in the general population is unclear. The authors examined associations of supplemental beta-carotene, retinol, vitamin A, lutein, and lycopene with lung cancer risk among participants, aged 50-76 years, in the VITamins And Lifestyle (VITAL) cohort Study in Washington State. In 2000-2002, eligible persons (n = 77,126) completed a 24-page baseline questionnaire, including detailed questions about supplement use (duration, frequency, dose) during the previous 10 years from multivitamins and individual supplements/mixtures. Incident lung cancers (n = 521) through December 2005 were identified by linkage to the Surveillance, Epidemiology, and End Results cancer registry. Longer duration of use of individual beta-carotene, retinol, and lutein supplements (but not total 10-year average dose) was associated with statistically significantly elevated risk of total lung cancer and histologic cell types; for example, hazard ratio = 2.02, 95% confidence interval: 1.28, 3.17 for individual supplemental lutein with total lung cancer and hazard ratio = 3.22, 95% confidence interval: 1.29, 8.07 for individual beta-carotene with small-cell lung cancer for >4 years versus no use. There was little evidence for effect modification by gender or smoking status. Long-term use of individual beta-carotene, retinol, and lutein supplements should not be recommended for lung cancer prevention, particularly among smokers.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several epidemiological studies show that diets rich in fruits and vegetables reduce the risk of developing several chronic diseases, such as type 2 diabetes, atherosclerosis, and cancer. These diseases are linked with systemic, low grade chronic inflammation. Although controversy persists on the bioactive ingredients, several secondary plant metabolites have been associated with these beneficial health effects. Carotenoids represent the most abundant lipid-soluble phytochemicals, and in vitro and in vivo studies have suggested that they have anti-oxidant, anti-apoptotic, and anti-inflammatory properties. Recently, many of these properties have been linked to the effect of carotenoids on intracellular signaling cascades, thereby influencing gene-expression and protein translation. By blocking the translocation of NF-κB to the nucleus, carotenoids are able to interact with the NF-κB pathway, and thus, inhibit the downstream production of inflammatory cytokines, such as IL-8 or PGE-2. Carotenoids can also block oxidative stress by interacting with the Nrf-2 pathway, enhancing its translocation into the nucleus, and activating phase II enzymes and antioxidants, such as glutathione-S-transferases. In this review, which is organized into in vitro, animal, and human investigations, we summarized current knowledge on carotenoids and metabolites with respect to their ability to modulate inflammatory and oxidative stress pathways and discussed potential dose-health relations. While many pathways involved in the bioactivity of carotenoids have been revealed, future research should be directed on dose-response relations of carotenoids, their metabolites, and their effect on transcription factors and metabolism.
    Nutrition Research 11/2014; · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Biologically active compounds are considered as powerful food factors that elicit profound effects on the maintenance of human health, and disease prevention. The research into how bioactive compounds work and their role in disease prevention in vitro and in vivo is rapidly expanding. Carotenoids are one among several classes of biologically active compounds that have been reported to possess greater antioxidant and anti-cancer activity. Today, this emerging class of nutrients is the driving force in the nutritional supplement industry, and serves as a new frontier in cancer and cardiovascular research. Cancer is one of the leading causes of death worldwide. It is the second most common disease responsible for maximum mortality with about 8.2 million deaths, and the global cancer burden rises to 14.1 million new cases in 2012. This review mainly focused to summarize the anti-cancer therapeutic targets of carotenoids by highlighting the important hallmarks of cancer in terms of (i) cell cycle arrest, (ii) resistance to apoptosis, (iii) metastasis and (iv) angiogenesis alongside the relation of carotenoids in cancer epidemiology.
    Journal of Functional Foods 11/2014; · 4.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer has multiple risk factors and tobacco is the main one. Diet plays a role, but no clear effect has been consistently observed for different fruit and vegetable consumption. We aim to assess the association between fruit and vegetable consumption and lung cancer risk through a hospital-based case-control study in Spanish population. We recruited incident lung cancer cases in 2 Spanish hospitals from 2004 to 2008. Controls were individuals attending hospital for trivial surgery. Cases and controls were older than 30 and did not have a neoplasic history. We collected information on lifestyle with special emphases on tobacco and dietary habits. We included 371 cases and 496 controls. We found no protective effect for overall fruit consumption. For green leafy vegetables, the odds ratio (OR) was 0.92 [95% confidence interval (CI) = 0.32-2.69), and for other vegetables the OR was 0.77 (95% CI = 0.40-1.48) for the categories compared. We observed a reduced risk for broccoli and pumpkin intake. Although fruit consumption does not seem to be associated with a lower lung cancer risk, only the frequent consumption of specific green leafy vegetables and other vegetables might be associated with a reduced risk of lung cancer.
    Nutrition and Cancer 08/2014; · 2.47 Impact Factor


Available from